Expiring federal contract · order under a contract vehicle
75A50325F80025 — Heyltex Corporation
Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
- Contract / PIID
- 75A50325F80025
- Incumbent
- Heyltex Corporation
- Incumbent UEI
- GY2TKDGQA2L7
- Current end date
- September 29, 2027
- Potential total value
- $16,199,859
- Obligated
- $16,199,859
- NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- September 30, 2025
- Place of performance
- TX
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.
What the contract covers
PRUSSIAN BLUE (RADIOGARDASE), INSOLUBLE CAP, 500MG
Likely rebid window (estimate)
- Sources Sought / RFI: about Sep 2026 – Mar 2027 (6–12 months before the end date)
- RFP: about May 2027 – Jul 2027 (2–4 months before the end date)
Now inside the estimated Sources Sought / RFI window.
This is an order under contract vehicle V797D70258. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: 2 recorded changes to the end date, value or incumbent. Sign up to see each one.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Health and Human Services (NAICS 325412)
- 75H71226F80004 — Mckesson Corporation · ends November 25, 2026 · $114K
- 75H71224P00137 — Four Points Technology, L.L.C. · ends November 30, 2026 · $240K
- 75H71226F80005 — Mckesson Corporation · ends December 21, 2026 · $1.6M
- 75H71026P00562 — Mckesson Corporation · ends December 31, 2026 · $131K
- 75N92026P00029 — Medunik USA INC · ends December 31, 2026 · $210K
- 75N93024P01131 — United Biopharma, INC. · ends December 31, 2026 · $400K
- 75A50120C00092 — Phlow Corp. · ends January 13, 2027 · $697M
- 75D30123C17978 — Mckesson Specialty Distribution LLC · ends January 31, 2027 · $204M
- 75N95019F00088 — Mriglobal · ends January 31, 2027 · $2.4M
- 75N90024F00080 — Ino Therapeutics LLC · ends February 28, 2027 · $115K